CEO Göran Forsberg comments on the quarterly report
Watch the interview hereDavid Liberg, CSO Cantargia, presents at Redeye Autoimmune & Inflammatory Disease Event
Watch the interview hereRedeye interviews CEO Göran Forsberg about new results for nadunolimab monotherapy and IL1RAP as a biomarker presented at AACR
Watch the interview in Swedish here